Year | Volume (Price x Shares) | Change |
---|---|---|
2024 | $18.79 M | -84.41% |
2023 | $0.12 B | 113.2% |
2022 | $56.53 M | -68.82% |
2021 | $0.18 B | 692.67% |
2020 | $22.87 M | -91.87% |
2019 | $0.28 B | -34.7% |
2018 | $0.43 B | 582.42% |
2017 | $63.16 M | 35.85% |
2016 | $46.49 M | 196.68% |
2015 | $15.67 M | 54.27% |
2014 | $10.15 M | 537.98% |
2013 | $1.59 M |
Company | FTD volume (3months) | FTD volume (1 year) | Country |
---|---|---|---|
Johnson & Johnson JNJ | $0.13 B | $0.59 B | ๐บ๐ธ USA |
Novartis NVS | $18.64 M | $83.53 M | ๐จ๐ญ Switzerland |
Pfizer PFE | $10.32 M | $0.31 B | ๐บ๐ธ USA |
Amgen AMGN | $52.25 M | $0.21 B | ๐บ๐ธ USA |
Sanofi SNY | $21.22 M | $52.23 M | ๐ซ๐ท France |
Merck MRK | $6.57 M | $0.15 B | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $18.31 M | $24.09 M | ๐ฌ๐ง UK |
Seagen
SGEN | N/A | $37.49 M | ๐บ๐ธ USA |
Dr. Reddy's RDY | $2.89 M | $11.31 M | ๐ฎ๐ณ India |